Skip to main content

Olux News

FDA Medwatch Alert: Taro Pharmaceuticals Issues Voluntary Nationwide Recall of Clobetasol Propionate Ointment USP, 0.05%, 60 g Tubes, Lot AC13786 Due to Microbial Contamination

Hawthorne, NY, December 27, 2021 ─ Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g tubes,...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Contact Dermatitis, Atopic Dermatitis, Dermatitis, Eczema, Dermatological Disorders, Psoriasis, Lichen Planus, Lichen Sclerosus

Olux patient information at Drugs.com